Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic areas of cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, anti-TB, cephalosporins, and nonsteroidal anti-inflammatory drug therapies. In addition, it provides chronic therapies, and hospital-based products; products for diabetes and iron supplements for anemia, and a Budesonide-Formoterol combination for asthma. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consisting of labs and collection centers. The company has a strategic collaboration with TB Alliance to support the clinical development and commercialization of Telacebec for the treatment of tuberculosis, leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Low
1,875.00
High
2,529.50
Low
2,187.70
High
2,217.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Lupin Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LUPIN Lupin Limited | 2,195.10 | 0.29% | 17.16 | 127.94 | 1.00 L Cr | 12.02% | 13.91% | 2,529.50 / 1,875.00 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 418.00 | 0.78% | 19.97 | 20.93 | 3,815 | 5.53% | 20.38% | 534.55 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 816.10 | 1.59% | 34.73 | 23.50 | 7,400 | 13.69% | 14.28% | 946.10 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,250.00 | 0.50% | 34.55 | 759.88 | 55,774 | 4.25% | 23.36% | 32,900.00 / 25,150.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 14.38 | 0.07% | 5.93 | 2.42 | 764 | 5.95% | 58.02% | 17.27 / 9.08 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,650.00 | 0.24% | 40.18 | 90.83 | 45,595 | 6.17% | 30.87% | 3,796.00 / 2,329.90 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 750.00 | 0.39% | 39.37 | 19.05 | 11,483 | 9.97% | 35.62% | 775.00 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,357.00 | 0.95% | 27.68 | 49.03 | 16,506 | 17.17% | 28.10% | 1,418.00 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,395.00 | 0.09% | 29.90 | 180.45 | 64,536 | 2.73% | 7.93% | 5,933.50 / 5,075.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 533.25 | 2.22% | 28.56 | 18.67 | 1,541 | 0.38% | 23.27% | 790.95 / 482.80 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 818.75 | 0.57% | 23.22 | 35.27 | 16,150 | 0.15% | 20.51% | 998.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 7,400.00 | 1.43% | 109.07 | 67.85 | 18,500 | 11.24% | 18.49% | 9,849.50 / 7,371.50 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,614.90 | 0.43% | 25.23 | 64.00 | 92,918 | 4.09% | 41.78% | 1,682.40 / 1,016.10 |